
    
      This is a multi-centre , randomised, placebo-controlled study in parallel groups in 1680
      frail elderly subjects over the age of 70 years, living at home, monitored for a period of 3
      years. The subjects will be randomised into one of the following 4 groups:

        -  Omega-3 group: 800 mg/day of docosahexaenoic acid (V0137CA nutritional supplement)

        -  Omega-3 + multi-domain intervention group: 800 mg/day of docosahexaenoic acid ( V0137CA)

        -  Placebo + multi-domain intervention group

        -  Placebo group The multi-domain intervention includes training / information sessions in
           the following 4 areas: nutrition, physical activity, cognitive training and social
           activities, and preventive consultations.

      Selected subjects will present at least one of the following frailty criteria:

        -  Loss of one Instrumental Activity Daily Living (IADL)

        -  Subjective memory complaints to a physician

        -  Slow walking speed. Follow-up visits will occur every six months for 3 years for both
           dispensing of supplement and compliance (months 6, 12, 18, 24, 30 and 36) and
           neuropsychological and functional assessment (months 6, 12, 24, 36).
    
  